SHA:600211 Market Cap

SHA:600211 has a market cap or net worth of 13.28 billion as of April 29, 2026. Its market cap has increased by 8.20% in one year.

Market Cap

13.28B

Enterprise Value

11.01B

Revenue

2.98B

Ranking

n/a

PE Ratio

14.15

Stock Price

41.19

Market Cap Chart

Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 13.28B, an increase of 816.84%. That is a compound annual growth rate of 8.71%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	12.91B	-5.88%
Dec 31, 2025	13.71B	15.19%
Dec 31, 2024	11.91B	-1.59%
Dec 29, 2023	12.10B	35.86%
Dec 30, 2022	8.91B	-31.40%
Dec 31, 2021	12.98B	-22.18%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shanghai Shyndec Pharmaceutical	12.82B
Shenzhen Chipscreen Biosciences	13.08B
Henan Lingrui Pharmaceutical	12.71B
Guobang Pharma	13.33B
Zhejiang Jiuzhou Pharmaceutical	12.48B
Ningbo Menovo Pharmaceutical	12.44B
Guangdong Taienkang Pharmaceutical	12.34B
Zhejiang Hisun Pharmaceutical	13.53B

Market Cap Rankings